UNSPSC 85364103: Diagnosis of atrophy of prostate

This classification denotes the group of activities that yields a diagnosis of Atrophy of prostate. Atrophy of prostate is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code N42. 2

UNSPSC 85364103 Diagnosis of atrophy of prostate is a Commodity code that nominally addresses individual diagnostic services for prostate atrophy, yet recent state and local procurement activity under this code does not reflect targeted purchases of that specific diagnostic service. Instead, the three most recent opportunities tagged to this code span diagnostic imaging systems infrastructure, special education contracted services, and temporary health professional staffing — none of which align with the code's stated scope of prostate atrophy diagnosis. The mismatch suggests either deliberate mistagging by issuing bodies or a systematic misalignment between the code's intended use and the activities state and local agencies are actually procuring under it. No concrete volume or frequency signal emerges from the recent opportunities to characterize demand for prostate atrophy diagnosis specifically under this code.

The recent opportunities originate from a county health system (San Mateo Medical Center, California), an independent school district (Birdville Independent School District, Texas), and a second county health system (Santa Clara Health System, California). San Mateo Medical Center posted an RFP for Diagnostic Imaging PACS (Picture Archiving and Communication System) implementation with a due date of October 21, 2026; Santa Clara Health System issued a non-exclusive multiple-award qualification vehicle for temporary health professional staffing across 13 ancillary clinical categories with a due date of October 7, 2026; and Birdville ISD posted competitive sealed proposals for special education contracted services due October 21, 2026. Geographic activity clusters in California (two of three opportunities) and Texas (one). The code's presentation warrants direct inquiry with issuing bodies before pursuing opportunities tagged to it, as recent procurement activity does not support a business development strategy grounded in prostate atrophy diagnostic services.